Xolair

Xolair (omalizumab) is a prescription biologic used to help manage allergic asthma and chronic hives. It works by targeting immunoglobulin E to reduce allergic reactions. This injectable therapy is designed for long-term symptom control. Seek medical guidance before use.

Xolair is used to treat moderate to severe persistent allergic asthma in patients who have a positive skin test or blood test for allergens. It is also approved for chronic idiopathic urticaria, a condition causing persistent hives without a known cause. Patients often ask, what is Xolair used for, and it helps reduce the frequency of asthma attacks and hives flare-ups.

Many patients report fewer allergy symptoms and improved breathing after starting Xolair therapy. Some experience a reduction in skin reactions like itching and swelling associated with chronic hives. Effects may take several weeks to become noticeable as the medication works gradually.

Xolair should be administered by a healthcare professional in a clinical setting. Patients with a history of severe allergic reactions should use caution. Keep emergency medical contact information readily available during treatment. Always inform your provider about current medications and health conditions before starting Xolair.

Xolair may interact with other biologics or immunosuppressants, potentially increasing infection risk. No specific drug interactions are widely documented, but caution is advised when combining with other therapies affecting the immune system. Alcohol and certain foods do not typically interact with Xolair, but discuss all substances with your healthcare provider.